A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
Public ClinicalTrials.gov record NCT03744676. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, multicenter, Phase 2 study to determine the safety, PK, and efficacy of lisocabtagene maraleucel (JCAR017) in subjects who have relapsed from, or are refractory to, two lines of immunochemotherapy for aggressive B-cell non-Hodgkin lymphoma (NHL) in the outpatient setting. Subjects will receive treatment with JCAR017 and will be followed for up to 2 years.
Study identification
- NCT ID
- NCT03744676
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 104 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 29, 2018 (Actual)
- Primary completion
- Sep 22, 2023 (Actual)
- Completion
- Sep 22, 2023 (Actual)
- Last update posted
- Feb 27, 2025
2018 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0057 | Los Angeles | California | 90048 | — |
| Local Institution - 0060 | Denver | Colorado | 80218 | — |
| Local Institution - 0089 | Miami | Florida | 33176 | — |
| Local Institution - 0081 | Orlando | Florida | 32804 | — |
| Local Institution - 0065 | Indianapolis | Indiana | 46237 | — |
| Local Institution - 0069 | Wichita | Kansas | 67124 | — |
| Local Institution - 0064 | Louisville | Kentucky | 40207 | — |
| Local Institution - 0101 | Southfield | Michigan | 48075 | — |
| Local Institution - 0052 | East Brunswick | New Jersey | 08816 | — |
| Local Institution - 0066 | Morristown | New Jersey | 07962 | — |
| Local Institution - 0041 | Albany | New York | 12208 | — |
| Local Institution - 0039 | Cincinnati | Ohio | 45236 | — |
| Local Institution - 0098 | Eugene | Oregon | 97401 | — |
| Local Institution - 0051 | Portland | Oregon | 97213 | — |
| Lancaster General Hospital | Lancaster | Pennsylvania | 17604 | — |
| Local Institution - 0037 | Greenville | South Carolina | 29615 | — |
| Local Institution - 0063 | Nashville | Tennessee | 37203 | — |
| Local Institution - 0097 | Dallas | Texas | 75230 | — |
| Local Institution - 0061 | San Antonio | Texas | 78229 | — |
| Baylor Scott and White Health | Temple | Texas | 76508 | — |
| Local Institution - 0096 | Tyler | Texas | 75702 | — |
| Local Institution - 0074 | Salt Lake City | Utah | 84143 | — |
| Local Institution - 0036 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03744676, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03744676 live on ClinicalTrials.gov.